The Integration Imperative: Solving the "Interface Crisis" in End-to-End Continuous Bioprocessing
For decades, the biopharmaceutical industry has been tantalized by the promise of continuous manufacturing. The vision is compelling: a streamlined,...
bioprocessing
The Digital Imperative: Why Bioprocessing Must Abandon the Paper Trail to Unlock the Future of Medicine
The bioprocessing industry stands at a critical juncture. As cell and gene therapies move from niche academic experiments to life-saving...
Cytiva Accelerates Bioprocessing Evolution: Facility Expansions, AI Integration, and Regulatory Milestones
In the rapidly evolving landscape of biopharmaceutical manufacturing, the ability to scale production while maintaining stringent quality standards remains the...
Redefining Bioprocessing: Cytomos Unveils the Future of Predictive Cell Analytics with AuraCyt® and Celledonia®
In an era where biopharmaceutical manufacturing is racing to meet the demands of personalized medicine and complex cell therapies, the...
Revolutionizing ATMP Manufacturing: The Rise of Continuous Bioprocessing
The manufacturing of Advanced Therapy Medicinal Products (ATMPs)—including gene therapies and cell-based treatments—has long been hampered by the limitations of...
